Navigation Links
Drug Discovery Technologies, BCC Research
Date:9/6/2012

industry.METHODOLOGY AND INFORMATION SOURCES Both primary and secondary research methodologies were used in preparing this report. The research methodology was more qualitative than quantitative in nature and employed a triangulating approach, which aids validity. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already-marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. A patent search and analysis was also conducted.

In a second phase, a series of semi-structured interviews was conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotech and pharmaceutical companies. Other resources included academic institutions and technology and consulting companies. These were a rich source of data. Subsequent analysis of the documents and interview notes was iterative.

INTENDED AUDIENCE

This report is intended for business development professionals, entrepreneurs and other investment groups in order to fully understand and properly evaluate each segment in the drug discovery technology market. It provides a company's corporate development department with new insight into competitors' positions and reveals new opportunities otherwise overlooked or less known to the public.

ANALYST CREDENTIALS

Dr. Marianna Tcherpakov has more than eight years of experience as a bench scientist specializing in the area of biochemistry, cell biology, and industrial assay development. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and likely future developments.

TABLE OF CONTENTS CHAPTER ONE: INTRODUCTION 1

STUDY G
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device
2. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
3. Zenobia Therapeutics Announce A Partnership With The Alzheimers Drug Discovery Foundation
4. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
5. Omeros Announces Discovery in MASP-2 Program
6. Discovery Labs Receives US Patent for Method to Promote Mucus Clearance with Pulmonary Surfactant
7. Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
8. Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession
9. Tetra Discovery Partners Receives Major NIH Award To Develop New Alzheimers Drug
10. AMRI Further Expands Discovery Capabilities in India
11. Drug Discovery Technologies Market Soars to $79 billion by 2017, Driven by Innovations in Pipeline and Tools Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... supplier of injectable drug delivery systems, today announced ... and facilities in response to increasing demand from ... services. During the fourth quarter of fiscal year ... capital expenditures and R&D above normal quarterly investments. ...
(Date:7/30/2014)... N.Y. , July 30, 2014 /PRNewswire-iReach/ -- ... -based medical device company, has announced today ... the velox CD™ Vascular Closure Device. Velox CD™ ... immediate hemostasis following percutaneous femoral procedures. The single ... broadly ranging in size from 5F to 8F.  ...
(Date:7/30/2014)... -- InnoPharma, Inc. today announced the first generic launch of ... injection), in Canada.  Olanzapine is indicated for the rapid ... schizophrenia or bipolar I mania. As the ... into an agreement with Sandoz Canada Inc., pursuant to ... market and distribute Olanzapine Injection in Canada ...
Breaking Medicine Technology:Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 2Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 3Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 4Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers 5Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device 2InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2
... SIRO Clinpharm a leading Contract Research Organization (CRO) based out ... Nimita Limaye, PhD, SIRO Vice President and Global Head, Strategic Data ... the Society for Clinical Data Management (SCDM).   "I ... I hope that I will live up to the ...
... At this year,s Annual Meeting of the American ... (NYSE: PHG, AEX: PHI) is demonstrating how the ... simplify the clinician and patient experience. ... http://www.newscom.com/cgi-bin/prnh/20091127/NY17547LOGO ) Specially designed ...
Cached Medicine Technology:SIRO Clinpharm's Nimita Limaye Elected as Chairperson of Society for Clinical Data Management (SCDM) 2Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning 2Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning 3Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning 4
(Date:7/30/2014)... Denver, Colorado (PRWEB) July 30, 2014 Daily ... Barry promises to be an effective way to stop anxiety ... the program has already helped no less than 150,000 people ... indicates that this is a complex anxiety treatment system that ... for good. The whole method is very simple to access, ...
(Date:7/30/2014)... Rancho Cucamonga, CA (PRWEB) July 30, 2014 ... career learning how to make millions. However, like most people, ... all. Determined to find a better way, Paul carefully ... lasting wealth and those who do not. Based on the ... learned to not only improve his life and health, but ...
(Date:7/30/2014)... WHAT: , Resistance to artemisinin, the main drug ... Asia, among the Plasmodium falciparum ( ... and is likely caused by a genetic mutation ... artemisinin-based combination therapyas opposed to a standard three-day ... cases, according to findings published today in the ...
(Date:7/30/2014)... 30, 2014 Volunteers from the Church ... drug abuse this summer with massive distribution of ... can find these volunteers on Strøget, the famous Copenhagen ... for its shopping and its ambiance, some quarter of ... typical summer day. , These activities are part ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Visitors to ... contributed over $8,500 to ensure its protection. Bob Kiesendahl, ... a check to the Delaware Highlands Conservancy for donations ... The small $2-per-stay donations add up fast, as visitors ... the Upper Delaware River Region. , The Kiesendahl family ...
Breaking Medicine News(10 mins):Health News:Panic Away Review Reveals How to Stop Anxiety 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 3Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2
... June 10 Law Offices of Howard G. Smith,announces ... a lead plaintiff in the,securities class action lawsuit filed ... the common stock of Healthways, Inc.,("Healthways" or the "Company")(Nasdaq: ... 2008 (the "Class Period"), including shares acquired through,the Company,s ...
... The aging process often forces older adults ... including their independence and the ability to exercise ... University of Missouri Center for Eldercare and Rehabilitation ... live better lives by developing and evaluating motion-capture ...
... Sen. Olympia Snowe,(R-ME), member of the Senate Finance ... that includes pharmacy-related provisions to provide,prompt payment of ... the,implementation of Medicaid reimbursement cuts for generic prescription,drugs. ... Pharmacy Inc. in,Camden, ME and a member of ...
... 10 Ask any entertainment or electronics,junkie and they ... while watching,your favorite TV show in HD won,t save ... (See video from Siemens (NYSE: SI ... system from Siemens is the world,s first to,utilize high-definition ...
... machine revenue seen as possible way to expand access., ... that everyone in the state should have access to ... by AARP Maryland.,In fact, 93 percent of Maryland voters ... gender and party affiliation., The same survey found ...
... Offered to Local Seniors, SAN FRANCISCO, June ... opportunity to exercise their brains through the Brain ... a partnership with San,Francisco-based Posit Science. The Brain ... processing, memory and other cognitive functions,with participants reporting ...
Cached Medicine News:Health News:Law Offices of Howard G. Smith Announces Update to the Shareholder Lawsuit Against Healthways, Inc. 2Health News:MU researchers enhancing motion-capture technology to benefit older adults 2Health News:Maine Community Pharmacy Owner Thanks Sen. Snowe for Supporting Inclusion of Common-Sense Reimbursement Provisions in Medicare Bill 2Health News:Survey: Maryland Voters Concerned About Health Care 2Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 2Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 3
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
... The "three-in-one Microkeratome for traditional Lasik, Epi-Lasik ... a world of rapidly changing technologies and ... II is and remains a proven value, ... their needs and allows them to stay ...
Medicine Products: